I have learned through my investigations this past week that Opexa is seeking funding for Tovaxin in order to continue the clinical trials. They are looking at a program called Fast Forward. If they are successful with their proposal to Fast Forward, there is a good possibility they could obtain partial funding to continue the trial and Fast Forward could assist Opexa in obtaining additional research funding to finish the trial.
This is good news! I will keep you updated.
“When everything seems to be going against you, remember that the airplane takes off against the wind, not with it.” - Henry Ford